BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

Health Issues HCR

21st Century Cures Act 2.0 ---House Energy and Commerce Discussion Draft ---RFI from House Energy and Commerce Committee Biodefense Research, Development and Procurement Issues (Non-Funding) ---Executive Order on Modernizing Influenza Vaccines --- Implementation of 21st Century Cures Act of 2016 --- Implementation of Pandemic and All-Hazards Preparedness and Advancing Innovation (PAHPAI) Act of 2019 --- Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 --- Implementation of the Families First Coronavirus Response Act of 2020 ---White House National Biodefense Strategy Biosimilars ---BSUFA Negotiations ---Reimbursement --- H.R. 2891/S.1428, the Preserve Access to Affordable Generics and Biosimilars Act; Coronavirus (COVID-19) Pandemic ---H.R.133: Consolidated Appropriations Act for FY 2021 ---H.R.869/S.289: Research Investment to Spark the Economy (RISE) Act of 2021 ---H.R.1319: American Rescue Plan Act of 2021 ---COVID-19 Lessons Learned ---COVID-19 Pricing-Related Provisions ---COVID-19 Vaccine Distribution ---Defense Production Act (DPA) ---Drug Supply Chain Management ---Healthcare Disparities ---Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 --- Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 --- Implementation of the Families First Coronavirus Response Act of 2020, ---Medicare Reimbursement Policies ---Monoclonal Antibody Coverage and Utilization ---Patient Cost-Sharing and Smoothing ---PREP Act COVID-19 Declaration Coverage for Private Sector Procurement ---R&D Funding for Medical Countermeasures ---Senate HELP Pandemic Preparedness White Paper ---Supply Chain Issues ---TRIPS IP Waiver ---Temporarily Refundable R&D Credit ---NOL Monetization Diagnostics and Personalized Medicine Regulation and Oversight --- VALID Act (Discussion Draft) Diversity & Inclusion ---Clinical Trial Diversity ---ENACT Act ---DEPICT Act ---DIVERSE Act Drug Evaluation and Review ---COVID-19 Lessons Learned ---Compassionate Use/Expanded Access ---Expedited Pathways ---FDA Hiring Flexibility ---FDA Management and Financial Accountability ---Patient-Focused Drug Development ---Implementation of the Prescription Drug User Fee Act (PDUFA) VI ---Innovation Incentives ---Prescription Drug User Fee Act (PDUFA) VII Priorities ---Priority Review Voucher Programs ---Promising Pathway Act (Discussion Draft) ---Regulatory Reform & Modernization ---Use of Real-World Evidence ---Advisory Committee Enhancements Drug Importation ---Medicare Negotiation and Competitive Licensing Act (Discussion Draft) Drug Manufacturing, Quality & Distribution ---A bill to amend the Internal Revenue Code of 1986 to provide for credits against tax for domestic medical and drug manufacturing and advanced medical manufacturing equipment. (Discussion Draft) ---Inspections Drug Patenting ---H.R.19/S.2164: Lower Costs, More Cures Act of 2021 ---H.R.153: Protecting Consumer Access to Generic Drugs Act of 2021 ---H.R.2873: Affordable Prescriptions for Patients Through Promoting Competition Act of 2021 ---H.R.2884: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2021 --- H.R. 2891 Preserve Access to Affordable Generics and Biosimilars ---S.1435: Affordable Prescriptions for Patients Act of 2021 ---Lower Health Care Costs for Patients Act (Discussion Draft) ---Medicare Negotiation and Competitive Licensing Act (Discussion Draft) ---Restrictions on Intellectual Property Rights Drug Pricing ---H.R.3: Elijah E. Cummings Lower Drug Costs Now Act ---S.1435: Affordable Prescriptions for Patients Act of 2021 ---H.R.19/S.2164: Lower Costs, More Cures Act of 2021 ---H.R. 2883/S.1425: the Stop Stalling Access to Affordable Medications; ---H.R. 2891/S.1428: the Preserve Access to Affordable Generics and Biosimilars Act; ---H.R. 2873: the Affordable Prescriptions for Patients Through Promoting Competition Act of 2021; ---H.R. 2884: the Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act; ---H.R. 3684 - Infrastructure Investment and Jobs Act? ---S.1435, Affordable Prescriptions for Patients Act of 2021 ---S.632/H.R. 1732, IDEA Act ---HR 5125 Strengthening Innovation in Medicare/Medicaid ---EO 14036 on Competition in American Economy Under importation ---CMMI Authority ---COVID-19 Pricing-Related Provisions ---Drug Pricing Provisions ---Medicare Drug Price Negotiation Act (Discussion Draft) ---Prescription Drug Pricing Reduction Act (Discussion Draft) ---Reference Pricing in Drug Reimbursement ---Senate Finance Committee Drug Pricing Principles ---Strengthening Innovation in Medicare and Medicaid Act (Discussion Draft) Funding for Antimicrobial Resistance Programs ---FY 2022 Appropriations ---H.R.133: Consolidated Appropriations Act for FY 2021 ---H.R.1319: American Rescue Plan Act of 2021 ---H.R. 4127, the DISARM Act ---H.R. 8920/S.4760: Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act of 2021 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---FY 2022 Appropriations ---H.R.133: Consolidated Appropriations Act for FY 2021 ---H.R.1319: American Rescue Plan Act of 2021 ---H.R. 5376: Build Back Better Act ---Funding for Strategic National Stockpile ---Health Defense Operations Funding Designation ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 Funding for FDA ---H.R.133: Consolidated Appropriations Act for FY 2021 ---H.R.3743: Supporting the Foundation for the National Institutes of Health and the Reagan-Udall Foundation for the Food and Drug Administration Act ---Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Implementation of the Prescription Drug User Fee Act (PDUFA) VI ---Prescription Drug User Fee Act (PDUFA) VII Priorities Funding for Health Resources and Services Administration (HRSA) ---H.R.133: Consolidated Appropriations Act for FY 2021 ---H.R.1319: American Rescue Plan Act of 2021 Funding for National Institutes of Health ---FY 2022 Appropriations ---H.R.133: Consolidated Appropriations Act for FY 2021 ---H.R.1319: American Rescue Plan Act of 2021 ---H.R.3743: Supporting the Foundation for the National Institutes of Health and the Reagan-Udall Foundation for the Food and Drug Administration Act ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Advanced Research Projects Agency for Health (ARPA-H) Funding for the Centers for Disease Control and Prevention Vaccine Programs ---FY 2022 Appropriations ---H.R.133: Consolidated Appropriations Act for FY 2021 ---H.R.1319: American Rescue Plan Act of 2021 ---Funding for 2020-2021 Influenza Season Preparedness and Response ---Funding for Routine Immunization Infrastructure during Pandemic ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 Medicaid ---H.R.3: Elijah E. Cummings Lower Drug Costs Now Act ---H.R.2170/S.581: Helping Adults Protect Immunity (HAPI) Act of 2021 ---H.R.2347: Strengthening the Vaccines for Children Program Act of 2021 ---Pricing and Rebates ---Senate Finance Committee Drug Pricing Principles ---Value-Based Purchasing (VBP) Rule ---Alternative Payment Arrangements for Gene Therapies ---Drug Benefit Design Opioid Crisis ---FDA Reforms Orphan Drug Issues ---H.R. 5376: Build Back Better Act ---Tax Credit Reimbursement and Coverage of Innovative Products ---H.R.3: Elijah E. Cummings Lower Drug Costs Now Act ---H.R.19/S.2164: Lower Costs, More Cures Act of 2021 ---Administrative Rebate Rule ---CMMI Authority ---Drug Pricing Provisions ---Medicare Part B Physician-Administered Products ---New Opportunities for Value that Extend Lives (NOVEL) Act (Discussion Draft) ---Patient Cost-Sharing and Smoothing ---Protected Classes ---Reference Pricing in Drug Reimbursement ---Senate Finance Committee Drug Pricing Principles ---Step Therapy ---Strengthening Innovation in Medicare and Medicaid Act (Discussion Draft) ---Value-Based Purchasing (VBP) Rule Vaccines and Infectious Diseases ---FY 2022 Appropriations ---H.R.133: Consolidated Appropriations Act for FY 2021 ---H.R.550: Immunization Infrastructure Modernization Act ---H.R.951: Maternal Vaccinations Act ---H.R.979: Vaccine Fairness Act ---H.R.1319: American Rescue Plan Act of 2021 ---H.R.1452: A bill to direct the Secretary of Health and Human Services to publish the formula the Secretary uses to determine the allocation of COVID-19 vaccines, and for other purposes. ---H.R.1550: Promoting Resources to Expand Vaccination, Education, and New Treatments for (PREVENT) HPV Cancers Act of 2021 ---H.R.1978: Protecting Seniors through Immunizations Act ---H.R.2170/S.581: Helping Adults Protect Immunity (HAPI) Act of 2021 ---H.R.2347: Strengthening the Vaccines for Children Program Act of 2021 ---H.R.3013: COVID Vaccine Transportation Access Act ---H.R.3655: Vaccine Injury Compensation Modernization Act of 2021 ---H.R.3742: Vaccine Information for Nursing Facility Operators (INFO) Act ---H.R.3743: Supporting the Foundation for the National Institutes of Health and the Reagan-Udall Foundation for the Food and Drug Administration Act ---H.R.4127: A bill to amend title XVIII of the Social Security Act to encourage the development and use of DISARM antimicrobial drugs, and for other purposes. ---H.R. 8920/S.4760: Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act of 2021 ---S.581: Helping Adults Protect Immunity (HAPI) Act of 2021 ---Adult Immunization ---Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---MCM Manufacturing & Capacity ---MCM R&D Incentives ---Vaccine Injury Compensation Program ---Vaccine and Antimicrobial Resistance Product Development and Incentives Vaccine Injury Compensation Program ---FY 2022 Appropriations ---H.R.3656: Vaccine Access Improvement Act of 2021

Contacted: Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Natl Economic Council (NEC); Centers For Medicare and Medicaid Services (CMS); Office of Science & Technology Policy (OSTP); Environmental Protection Agency (EPA); Commerce, Dept of (DOC); Small Business Administration (SBA); SENATE; Health & Human Services, Dept of (HHS); Natl Security Council (NSC); White House Office; Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); Agriculture, Dept of (USDA)

Bills named: H.R. 3684 (117th), H.R. 2170 (117th), H.R. 3656 (117th), H.R. 19 (117th), H.R. 2884 (117th), H.R. 3655 (117th), H.R. 951 (117th), H.R. 5125 (117th), H.R. 3742 (117th), S. 1428 (117th), S. 1425 (117th), H.R. 3743 (117th), H.R. 1732 (117th), H.R. 2347 (117th), S. 632 (117th), H.R. 3 (117th), H.R. 869 (117th), H.R. 2873 (117th), S. 2164 (117th), H.R. 3013 (117th), H.R. 1319 (117th), S. 289 (117th), H.R. 2891 (117th), H.R. 1550 (117th), H.R. 1978 (117th), H.R. 4127 (117th), S. 581 (117th), H.R. 8920 (117th), H.R. 5376 (117th), H.R. 153 (117th), H.R. 133 (117th), H.R. 979 (117th), H.R. 550 (117th), H.R. 2883 (117th), S. 4760 (117th), H.R. 1452 (117th), S. 1435 (117th)

Agriculture AGR

Climate Change ---S. 1251/H.R. 2820: The Growing Climate Solutions Act of 2020 ---FY 2022 Appropriations ---Climate Risk Disclosures ---Climate Issues & impact on the agriculture, food, and forestry sectors ---Fighting Climate Change through Biotechnology Innovation Foreign Agricultural Biotechnology Laws and Regulations ---China Biotechnology Regulations ---EU Ag-Biotech Policies and Regulations ---Mexico Draft Decree Banning Genetically Modified Corn ---Mexico Import Approval Delays of Ag Biotech Funding for the USDA ---FY 2022 Budget Resolution ---H.R.5305: Extending Government Funding and Delivering Emergency Assistance Act ---USDA Climate-Smart Agriculture and Forestry Partnership Initiative Genetically Engineered (GE) Animals ---H.R.5305: Extending Government Funding and Delivering Emergency Assistance Act ---H.R. 273: Prevention of Escapement of Genetically Altered Salmon in the United States Act ---Climate Issues & impact on the agriculture, food, and forestry sectors ---Efficient Science-Based Review of Biotech Products ---FDA Approvals, Guidance, & Regulations ---USDA proposed Regulation of the Movement of Animals Modified or Developed by Genetic Engineering Genetically Engineered (GE) Plants ---Climate Issues & impact on the agriculture, food, and forestry sectors USDA/APHIS Agricultural Biotechnology Regulations ---The Sustainable, Ecological, Consistent, Uniform, Responsible, Efficient (SECURE) Rule under the Plant Protection Act ---Climate Issues & impact on the agriculture, food, and forestry sectors ---USDA proposed Regulation of the Movement of Animals Modified or Developed by Genetic Engineering

Contacted: Centers For Disease Control & Prevention (CDC); Commerce, Dept of (DOC); White House Office; Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Office of Science & Technology Policy (OSTP); HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); SENATE; Patent & Trademark Office (PTO); Small Business Administration (SBA); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Agriculture, Dept of (USDA); Natl Economic Council (NEC); Centers For Medicare and Medicaid Services (CMS); Natl Security Council (NSC)

Bills named: H.R. 5305 (117th), H.R. 2820 (117th), H.R. 273 (117th), S. 1251 (117th)

Budget/Appropriations BUD

Coronavirus (COVID-19) Pandemic ---H.R.133: Consolidated Appropriations Act for FY 2021 ---H.R.1319: American Rescue Plan Act of 2021 ---H.R.5305: Extending Government Funding and Delivering Emergency Assistance Act ---H.R. 5376: Build Back Better Act ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 --- Implementation of the Families First Coronavirus Response Act of 2020 Funding for Antimicrobial Resistance (AMR) Programs ---H.R.133: Consolidated Appropriations Act for FY 2021 ---H.R.1319: American Rescue Plan Act of 2021 ---H.R. 8920/S.4760: Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act of 2021 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---H.R.133: Consolidated Appropriations Act for FY 2021 ---H.R.1319: American Rescue Plan Act of 2021 ---H.R.5305: Extending Government Funding and Delivering Emergency Assistance Act ---H.R. 5376: Build Back Better Act ---Funding for Strategic National Stockpile ---Health Defense Operations Funding Designation ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 --- Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 Funding for Biofuels, Biomass Crop Assistance, and Biorefineries ---FY 2022 Budget Resolution --- H.R.5305: Extending Government Funding and Delivering Emergency Assistance Act ---Climate Issues & impact on the agriculture, food, and forestry sectors ---Incentives for Sustainable Aviation Fuels --- USDA Climate-Smart Agriculture and Forestry Partnership Initiative Funding for FDA ---FY 2022 Budget Resolution --- H.R.5305: Extending Government Funding and Delivering Emergency Assistance Act ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Implementation of the Prescription Drug User Fee Act (PDUFA) VI ---Prescription Drug User Fee Act (PDUFA) VII Priorities Funding for Health Resources and Services Administration (HRSA) Funding for National Institutes of Health ---H.R.133: Consolidated Appropriations Act for FY 2021 ---Advanced Research Projects Agency for Health (ARPA-H) Funding for the Centers for Disease Control and Prevention Vaccine Programs ---H.R.1319: American Rescue Plan Act of 2021 --- Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Funding for 2020-2021 Influenza Season Preparedness and Response ---Funding for Routine Immunization Infrastructure during Pandemic Funding for the USDA --- H.R.5305: Extending Government Funding and Delivering Emergency Assistance Act ---Biotechnology and Agriculture Trade Program ---FY 2022 Budget Resolution --- USDA Climate-Smart Agriculture and Forestry Partnership Initiative

Contacted: Natl Institutes of Health (NIH); Small Business Administration (SBA); Natl Security Council (NSC); SENATE; Centers For Disease Control & Prevention (CDC); Commerce, Dept of (DOC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); Agriculture, Dept of (USDA); Centers For Medicare and Medicaid Services (CMS); White House Office; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Office of Science & Technology Policy (OSTP); Patent & Trademark Office (PTO); Environmental Protection Agency (EPA)

Bills named: H.R. 133 (117th), H.R. 5305 (117th), H.R. 8920 (117th), H.R. 1319 (117th), S. 4760 (117th), H.R. 5376 (117th)

Taxation/Internal Revenue Code TAX

Capital Formation Incentives ---H.R.2140/S.961: American Innovation Act ---H.R.3448: Helping Startups Continue to Grow Act ---H.R. 5376: Build Back Better Act ---A bill to amend the Internal Revenue Code of 1986 to add a new medical research component to the credit for increasing research activities (Discussion Draft) ---A bill to amend the Internal Revenue Code of 1986 to make a portion of research credit refundable for certain small businesses engaging in specified medical research. (Discussion Draft) ---Incentives for Sustainable Aviation Fuels ---Proposed amendments under the Exchange Act of 1934 ---Proposed amendments under the Investment Company Act of 1940 ---Proposed amendments under the Securities Act of 1933 ---IGNITE American Innovation Act (Discussion Draft) ---Reform of Net Operating Loss Rules Research & Development Tax Credit Reforms ---H.R.2140/S.961: American Innovation Act ---A bill to amend the Internal Revenue Code of 1986 to provide for credits against tax for domestic medical and drug manufacturing and advanced medical manufacturing equipment. (Discussion Draft) ---Expensing of R&D Expenditures Vaccine Injury Compensation Program ---H.R.3656: Vaccine Access Improvement Act of 2021

Contacted: Patent & Trademark Office (PTO); Centers For Disease Control & Prevention (CDC); Office of Science & Technology Policy (OSTP); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Agriculture, Dept of (USDA); Environmental Protection Agency (EPA); Natl Economic Council (NEC); Small Business Administration (SBA); Centers For Medicare and Medicaid Services (CMS); SENATE; Natl Security Council (NSC); White House Office; HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC)

Bills named: H.R. 5376 (117th), S. 961 (117th), H.R. 2140 (117th), H.R. 3656 (117th), H.R. 3448 (117th)

Copyright/Patent/Trademark CPT

Antitrust Legislation ---S.225: Competition and Antitrust Law Enforcement Reform Act of 2021 --- H.R. 2891 Preserve Access to Affordable Generics and Biosimilars ---General Bayh-Dole Act/Tech Transfer ---Bayh-Dole Act ---March-In Rights ---NIST Proposed Rulemaking on Bayh-Dole Compulsory Licensing --- H.R.4811 - Medicare Negotiation and Competitive Licensing Act of 2021 --- Medicare Negotiation and Competitive Licensing Act (Discussion Draft) --- Prescription Drug Price Relief Act (Discussion Draft) --- We Protect American Investment in Drugs Act (Discussion Draft) Coronavirus (COVID-19) Pandemic ---Restrictions on Intellectual Property Rights ---TRIPS Waiver Diversity in Patenting ---35 USC Section 101 on Patent Eligibility ---S.632: Inventor Diversity for Economic Advancement (IDEA) Act of 2021 Drug Patenting ---H.R.19/S.2164: Lower Costs, More Cures Act of 2021 ---H.R.153: Protecting Consumer Access to Generic Drugs Act of 2021 ---H.R.2873: Affordable Prescriptions for Patients Through Promoting Competition Act of 2021 ---H.R.2884: Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2021 ---S.1435: Affordable Prescriptions for Patients Act of 2021 ---Medicare Negotiation and Competitive Licensing Act (Discussion Draft) ---Restrictions on Intellectual Property Rights Intellectual Property Enforcement ---China ---TRIPS Waiver Inter Partes Review --- S.2891 Restoring the America Invents Act --- S.2774 Pride in Patent Ownership Act ---Support Technology and Research for Our Nations Growth and Economic Resilience (STRONGER) Patents Act (Discussion Draft) Patent Reform ---S.1260: United States Innovation and Competition Act of 2021 ------Ownership and Assignments of Patents --- S.2774 Pride in Patent Ownership Act ---Patent Litigation Reforms Patenting of Biological Inventions ---35 USC Section 101 on Patent Eligibility ---Section 101 Modernization United States-Mexico-Canada Agreement (USMCA) ---Implementation of USMCA US-China Trade Agreement ---IP Provisions

Contacted: White House Office; Natl Security Council (NSC); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Natl Economic Council (NEC); Office of Science & Technology Policy (OSTP); Patent & Trademark Office (PTO); Commerce, Dept of (DOC); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Small Business Administration (SBA); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Agriculture, Dept of (USDA); Environmental Protection Agency (EPA); SENATE; Natl Institutes of Health (NIH)

Bills named: H.R. 2884 (117th), S. 225 (117th), S. 2891 (117th), S. 1260 (117th), H.R. 4811 (117th), S. 632 (117th), S. 2164 (117th), S. 2774 (117th), H.R. 2891 (117th), H.R. 19 (117th), S. 1435 (117th), H.R. 2873 (117th), H.R. 153 (117th)

Trade (domestic/foreign) TRD

Digital Trade ---EU Digital Strategy Drug Pricing ---Drug pricing and reimbursement policy in Taiwan ---Reference Pricing in Drug Reimbursement Foreign Agricultural Biotechnology Laws and Regulations ---China Biotechnology Regulations ---EU Ag-Biotech Policies and Regulations ---Mexico Draft Decree Banning Genetically Modified Corn ---Mexico Import Approval Delays of Ag Biotech Intellectual Property International Enforcement ---China ---TRIPS Waiver The United States-Mexico-Canada Agreement (USMCA) ---Implementation of United States-Mexico-Canada Agreement (USMCA) ------Ag-Biotech Provisions ------IP Provisions ---Mexico Draft Decree Banning Genetically Modified Corn ---Mexico Import Approval Delays of Ag Biotech US-China Trade Agreement ---Ag-Biotech Provisions ---IP Provisions US-EU Trade Agreement ---Ag-Biotech Provisions World Trade Organization ---TRIPS Waiver World Health Organization (WHO) ---TRIPS Waiver

Contacted: White House Office; Small Business Administration (SBA); Natl Security Council (NSC); Commerce, Dept of (DOC); Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); Office of Science & Technology Policy (OSTP); Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Agriculture, Dept of (USDA); Natl Economic Council (NEC)

Small Business SMB

Capital Formation Incentives ---H.R.2140/S.961: American Innovation Act ---H.R.3448: Helping Startups Continue to Grow Act ---H.R. 5376: Build Back Better Act ---A bill to amend the Internal Revenue Code of 1986 to add a new medical research component to the credit for increasing research activities (Discussion Draft) ---A bill to amend the Internal Revenue Code of 1986 to make a portion of research credit refundable for certain small businesses engaging in specified medical research. (Discussion Draft) ---IGNITE American Innovation Act (Discussion Draft) ---Reform of Net Operating Loss Rules Capital Market Enhancements ---Market Liquidity Proposals Short Selling Transparency ---H.R. 4681-Short Sale Transparency and Fairness Act

Contacted: Commerce, Dept of (DOC); U.S. Trade Representative (USTR); Environmental Protection Agency (EPA); Natl Economic Council (NEC); Office of Science & Technology Policy (OSTP); White House Office; Natl Institutes of Health (NIH); SENATE; Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); Patent & Trademark Office (PTO); Small Business Administration (SBA); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Natl Security Council (NSC)

Bills named: H.R. 2140 (117th), S. 961 (117th), H.R. 3448 (117th), H.R. 5376 (117th), H.R. 4681 (117th)

Medicare/Medicaid MMM

21st Century Cures Act 2.0 ---RFI from House Energy and Commerce Committee 340B Drug Discount Program ---H.R.3203: A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes. ---Program Implementation & Oversight Coronavirus (COVID-19) Pandemic ---Implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act of 2020 ---Implementation of the Families First Coronavirus Response Act of 2020 ---Patient Cost-Sharing and Smoothing ---COVID-19 Pricing Related Provisions ---Immunization Information Systems Drug Manufacturing, Quality & Distribution ---A bill to amend the Internal Revenue Code of 1986 to provide for credits against tax for domestic medical and drug manufacturing and advanced medical manufacturing equipment. (Discussion Draft) Drug Pricing ---FY 2022 Appropriations ---H.R.3: Elijah E. Cummings Lower Drug Costs Now Act ---H.R.19/S.2164: Lower Costs, More Cures Act of 2021 ---H.R.5260: Reduced Costs and Continued Cures Act ---S.2327 - Seniors Prescription Drug Relief Act ---H.R. 5376: Build Back Better Act ---H.R.3684: Infrastructure Investment and Jobs Act ---CMMI Authority ---COVID-19 Pricing-Related Provisions ---Drug Pricing Provisions ---Prescription Drug Pricing Reduction Act (Discussion Draft) ---Reference Pricing in Drug Reimbursement ---Senate Finance Committee Drug Pricing Principles ---Strengthening Innovation in Medicare and Medicaid Act (Discussion Draft) Medicaid ---H.R.3: Elijah E. Cummings Lower Drug Costs Now Act ---H.R.2170/S.581: Helping Adults Protect Immunity (HAPI) Act of 2021 ---H.R.2347: Strengthening the Vaccines for Children Program Act of 2021 --- Alternative payment arrangements for gene therapies ---Drug Benefit Design ---Pricing and Rebates ---Senate Finance Committee Drug Pricing Principles ---Value-Based Purchasing (VBP) Rule Reimbursement and Coverage of Innovative Products ---H.R.3: Elijah E. Cummings Lower Drug Costs Now Act ---H.R.19/S.2164: Lower Costs, More Cures Act of 2021 ---Administration Rebate Rule ---CMMI Authority ---Drug Pricing Provisions ---Medicare Part B Physician-Administered Products ---New Opportunities for Value that Extend Lives (NOVEL) Act (Discussion Draft) ---Patient Cost-Sharing and Smoothing ---Protected Classes ---Reference Pricing in Drug Reimbursement ---Senate Finance Committee Drug Pricing Principles ---Strengthening Innovation in Medicare and Medicaid Act (Discussion Draft) ---Step Therapy ---Value-Based Purchasing (VBP) Rule ---Value-based Contracting and Communications Vaccines and Infectious Diseases ---H.R.1978: Protecting Seniors through Immunizations Act ---H.R.2170/S.581: Helping Adults Protect Immunity (HAPI) Act of 2021 ---H.R.2347: Strengthening the Vaccines for Children Program Act of 2021 ---H.R.4127: A bill to amend title XVIII of the Social Security Act to encourage the development and use of DISARM antimicrobial drugs, and for other purposes.

Contacted: Agriculture, Dept of (USDA); Natl Institutes of Health (NIH); U.S. Trade Representative (USTR); Natl Economic Council (NEC); Centers For Disease Control & Prevention (CDC); Office of Science & Technology Policy (OSTP); Commerce, Dept of (DOC); Small Business Administration (SBA); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); White House Office; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Natl Security Council (NSC)

Bills named: H.R. 19 (117th), H.R. 1978 (117th), H.R. 5260 (117th), H.R. 4127 (117th), H.R. 3 (117th), H.R. 3684 (117th), H.R. 2170 (117th), H.R. 3203 (117th), S. 2164 (117th), S. 2327 (117th), H.R. 5376 (117th), S. 581 (117th), H.R. 2347 (117th)

Chemicals/Chemical Industry CHM

Funding for Renewable Chemicals/Bio-based Products ---FY 2022 Budget Resolution --- H.R.5305: Extending Government Funding and Delivering Emergency Assistance Act --- H.R. 5376: Build Back Better Act --- USDA Climate-Smart Agriculture and Forestry Partnership Initiative Renewable Chemicals/Bio-based Products (Non-Funding) ---H.R.1512: The Climate Leadership and Environmental Action for Our Nations (CLEAN) Future Act of 2021 --- H.R.5305: Extending Government Funding and Delivering Emergency Assistance Act; ---H.R.2532: Renewable Chemicals Act of 2021 ---FY 2022 Budget Resolution --- Investment Tax Credit --- Production Tax Credit ---Climate Issues & impact on the agriculture, food, and forestry sectors ---USDA Climate-Smart Agriculture and Forestry Partnership Initiative

Contacted: Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); Commerce, Dept of (DOC); Natl Security Council (NSC); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); Agriculture, Dept of (USDA); White House Office; Office of Science & Technology Policy (OSTP); U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); SENATE; Small Business Administration (SBA)

Bills named: H.R. 5305 (117th), H.R. 1512 (117th), H.R. 5376 (117th), H.R. 2532 (117th)

Energy/Nuclear ENG

Biofuels (Non-Funding) ---H.R.1113: Renewable Fuel Standard Integrity Act of 2021 ---H.R.1512: The Climate Leadership and Environmental Action for Our Nations (CLEAN) Future Act of 2021 ---H.R.3249/S.1841: Financing Our Energy Future Act of 2019 ---H.R.3440/S.2263: Sustainable Skies Act of 2021 ---S.193: Adopt Greenhouse gases, Regulated Emissions, and Energy use in Transportation model (GREET) Act ---S.218: A bill to approve certain advanced biofuel registrations, to require the consideration of certain advanced biofuel pathways, and to reduce greenhouse gas emissions, and for other purposes. ---S.2118: Clean Energy for America Act of 2021 ---H.R.5305: Extending Government Funding and Delivering Emergency Assistance Act ---H.R. 5376: Build Back Better Act ---FY 2022 Budget Resolution ---A Clean Fuel Standard or Low Carbon Fuel Standard ---Climate Issues & impact on the agriculture, food, and forestry sectors ---Incentives for Sustainable Aviation Fuels ---Small Refinery Waivers ---Sustainable Aviation Fuels Tax Credit ---Proposed Rule to set 2021 Renewable Volume Obligations (RVOs) under the Renewable Fuel Standard and the 2022 RVO for Biomass-based Diesel ---USDA Climate-Smart Agriculture and Forestry Partnership Initiative Biomass Programs (Non-Funding) ---Climate Issues & impact on the agriculture, food, and forestry sectors Biorefineries (Non-Funding) ---Climate Issues & impact on the agriculture, food, and forestry sectors Climate Change ---FY 2022 Budget Resolution ---S. 1251/H.R. 2820: The Growing Climate Solutions Act of 2020 ---H.R.5305: Extending Government Funding and Delivering Emergency Assistance Act; ---H.R. 5376: Build Back Better Act ---Climate Issues & impact on the agriculture, food, and forestry sectors ---Fighting Climate Change through Biotechnology Innovation ---USDA Climate-Smart Agriculture and Forestry Partnership Initiative Funding for Biofuels, Biomass Crop Assistance, and Biorefineries ---FY 2022 Budget Resolution ---H.R.5305: Extending Government Funding and Delivering Emergency Assistance Act ---H.R. 5376: Build Back Better Act ---Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill for FY 2022 (Discussion Draft House) ---Climate Issues & impact on the agriculture, food, and forestry sectors ---Incentives for Sustainable Aviation Fuels ---USDA Climate-Smart Agriculture and Forestry Partnership Initiative Renewable Fuel Standard (RFS) ---H.R.1113: Renewable Fuel Standard Integrity Act of 2021 ---H.R.1512: The Climate Leadership and Environmental Action for Our Nations (CLEAN) Future Act of 2021 ---H.R.5305: Extending Government Funding and Delivering Emergency Assistance Act ---H.R. 5376: Build Back Better Act ---S.193: Adopt Greenhouse gases, Regulated Emissions, and Energy use in Transportation model (GREET) Act ---S.218: A bill to approve certain advanced biofuel registrations, to require the consideration of certain advanced biofuel pathways, and to reduce greenhouse gas emissions, and for other purposes. ---FY 2022 Budget Resolution ---A Clean Fuel Standard or Low Carbon Fuel Standard ---Cellulosic Registration Applications for Corn Kernel Fiber ---Climate Issues & impact on the agriculture, food, and forestry sectors ---RFS Reform ---Small Refinery Waivers ---Proposed Rule to set 2021 Renewable Volume Obligations (RVOs) under the Renewable Fuel Standard and the 2022 RVO for Biomass-based Diesel ---RFI from House Select Committee on the Climate Crisis ---USDA Climate-Smart Agriculture and Forestry Partnership Initiative

Contacted: Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); Office of Science & Technology Policy (OSTP); Food & Drug Administration (FDA); Commerce, Dept of (DOC); Agriculture, Dept of (USDA); Small Business Administration (SBA); Natl Security Council (NSC); U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); SENATE; Environmental Protection Agency (EPA); White House Office

Bills named: H.R. 2820 (117th), S. 1841 (117th), H.R. 1113 (117th), H.R. 3249 (117th), H.R. 1512 (117th), H.R. 5305 (117th), S. 218 (117th), S. 2263 (117th), H.R. 3440 (117th), S. 1251 (117th), H.R. 5376 (117th), S. 2118 (117th), S. 193 (117th)

Food Industry (safety, labeling, etc.) FOO

Genetically Engineered (GE) Animals ---H.R.5305: Extending Government Funding and Delivering Emergency Assistance Act ---H.R. 273: Prevention of Escapement of Genetically Altered Salmon in the United States Act ---Climate Issues & impact on the agriculture, food, and forestry sectors ---Efficient Science-Based Review of Biotech Products ---FDA Approvals, Guidance, & Regulations ---USDA proposed Regulation of the Movement of Animals Modified or Developed by Genetic Engineering

Contacted: HOUSE OF REPRESENTATIVES; Small Business Administration (SBA); Commerce, Dept of (DOC); Agriculture, Dept of (USDA); Natl Institutes of Health (NIH); Natl Security Council (NSC); Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA); U.S. Trade Representative (USTR); Centers For Disease Control & Prevention (CDC); SENATE; White House Office; Office of Science & Technology Policy (OSTP); Natl Economic Council (NEC); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Bills named: H.R. 273 (117th), H.R. 5305 (117th)

Animals ANI

Genetically Engineered (GE) Animals ---H.R.5305: Extending Government Funding and Delivering Emergency Assistance Act ---H.R. 273: Prevention of Escapement of Genetically Altered Salmon in the United States Act ---Climate Issues & impact on the agriculture, food, and forestry sectors ---Efficient Science-Based Review of Biotech Products ---FDA Approvals, Guidance, & Regulations ---USDA proposed Regulation of the Movement of Animals Modified or Developed by Genetic Engineering

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; White House Office; Natl Institutes of Health (NIH); Commerce, Dept of (DOC); Environmental Protection Agency (EPA); Natl Security Council (NSC); Natl Economic Council (NEC); Agriculture, Dept of (USDA); Centers For Disease Control & Prevention (CDC); Patent & Trademark Office (PTO); Office of Science & Technology Policy (OSTP); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Small Business Administration (SBA); Food & Drug Administration (FDA)

Bills named: H.R. 5305 (117th), H.R. 273 (117th)

Fuel/Gas/Oil FUE

Biofuels (Non-Funding) ---H.R.1113: Renewable Fuel Standard Integrity Act of 2021 ---H.R.1512: The Climate Leadership and Environmental Action for Our Nations (CLEAN) Future Act of 2021 ---H.R.3249/S.1841: Financing Our Energy Future Act of 2019 ---H.R.3440/S.2263: Sustainable Skies Act of 2021 ---S.193: Adopt Greenhouse gases, Regulated Emissions, and Energy use in Transportation model (GREET) Act ---S.218: A bill to approve certain advanced biofuel registrations, to require the consideration of certain advanced biofuel pathways, and to reduce greenhouse gas emissions, and for other purposes. ---S.2118: Clean Energy for America Act of 2021 ---H.R.5305: Extending Government Funding and Delivering Emergency Assistance Act ---H.R. 5376: Build Back Better Act ---FY 2022 Budget Resolution ---A Clean Fuel Standard or Low Carbon Fuel Standard ---Climate Issues & impact on the agriculture, food, and forestry sectors ---Incentives for Sustainable Aviation Fuels ---Small Refinery Waivers ---Sustainable Aviation Fuels Tax Credit ---Proposed Rule to set 2021 Renewable Volume Obligations (RVOs) under the Renewable Fuel Standard and the 2022 RVO for Biomass-based Diesel ---USDA Climate-Smart Agriculture and Forestry Partnership Initiative Biomass Programs (Non-Funding) ---Climate Issues & impact on the agriculture, food, and forestry sectors Biorefineries (Non-Funding) ---Climate Issues & impact on the agriculture, food, and forestry sectors Climate Change ---FY 2022 Budget Resolution ---S. 1251/H.R. 2820: The Growing Climate Solutions Act of 2020 ---H.R.5305: Extending Government Funding and Delivering Emergency Assistance Act; ---H.R. 5376: Build Back Better Act ---Climate Issues & impact on the agriculture, food, and forestry sectors ---Fighting Climate Change through Biotechnology Innovation ---USDA Climate-Smart Agriculture and Forestry Partnership Initiative Funding for Biofuels, Biomass Crop Assistance, and Biorefineries ---FY 2022 Budget Resolution ---H.R.5305: Extending Government Funding and Delivering Emergency Assistance Act ---H.R. 5376: Build Back Better Act ---Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill for FY 2022 (Discussion Draft House) ---Climate Issues & impact on the agriculture, food, and forestry sectors ---Incentives for Sustainable Aviation Fuels ---USDA Climate-Smart Agriculture and Forestry Partnership Initiative Renewable Fuel Standard (RFS) ---H.R.1113: Renewable Fuel Standard Integrity Act of 2021 ---H.R.1512: The Climate Leadership and Environmental Action for Our Nations (CLEAN) Future Act of 2021 ---H.R.5305: Extending Government Funding and Delivering Emergency Assistance Act ---H.R. 5376: Build Back Better Act ---S.193: Adopt Greenhouse gases, Regulated Emissions, and Energy use in Transportation model (GREET) Act ---S.218: A bill to approve certain advanced biofuel registrations, to require the consideration of certain advanced biofuel pathways, and to reduce greenhouse gas emissions, and for other purposes. ---FY 2022 Budget Resolution ---A Clean Fuel Standard or Low Carbon Fuel Standard ---Cellulosic Registration Applications for Corn Kernel Fiber ---Climate Issues & impact on the agriculture, food, and forestry sectors ---RFS Reform ---Small Refinery Waivers ---Proposed Rule to set 2021 Renewable Volume Obligations (RVOs) under the Renewable Fuel Standard and the 2022 RVO for Biomass-based Diesel ---RFI from House Select Committee on the Climate Crisis ---USDA Climate-Smart Agriculture and Forestry Partnership Initiative

Contacted: Office of Science & Technology Policy (OSTP); Commerce, Dept of (DOC); Natl Security Council (NSC); U.S. Trade Representative (USTR); Natl Economic Council (NEC); Centers For Disease Control & Prevention (CDC); Small Business Administration (SBA); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); Agriculture, Dept of (USDA); Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); SENATE; HOUSE OF REPRESENTATIVES; White House Office; Health & Human Services, Dept of (HHS)

Bills named: H.R. 5305 (117th), S. 1841 (117th), S. 1251 (117th), H.R. 3249 (117th), S. 2118 (117th), S. 2263 (117th), H.R. 3440 (117th), H.R. 1512 (117th), H.R. 2820 (117th), H.R. 5376 (117th), H.R. 1113 (117th), S. 218 (117th), S. 193 (117th)

Homeland Security HOM

Biodefense Research, Development and Procurement Issues (Non-Funding) ---White House National Biodefense Strategy Funding for Antimicrobial Resistance (AMR) Programs ---FY 2022 Appropriations ---H.R.133: Consolidated Appropriations Act for FY 2021 ---H.R.1319: American Rescue Plan Act of 2021 ---H.R. 8920/S.4760: Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act of 2021 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---FY 2022 Appropriations ---H.R.133: Consolidated Appropriations Act for FY 2021 ---H.R.1319: American Rescue Plan Act of 2021 ---Funding for Strategic National Stockpile ---Health Defense Operations Funding Designation ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020

Contacted: Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); Centers For Disease Control & Prevention (CDC); SENATE; HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Agriculture, Dept of (USDA); Natl Security Council (NSC); U.S. Trade Representative (USTR); White House Office; Commerce, Dept of (DOC); Environmental Protection Agency (EPA); Small Business Administration (SBA); Office of Science & Technology Policy (OSTP); Natl Economic Council (NEC)

Bills named: H.R. 1319 (117th), H.R. 8920 (117th), S. 4760 (117th), H.R. 133 (117th)

Medical/Disease Research/Clinical Labs MED

Biodefense Research, Development and Procurement Issues (Non-Funding) ---Executive Order on Modernizing Influenza Vaccines ---White House National Biodefense Strategy ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Implementation of the Families First Coronavirus Response Act of 2020 ---Pandemic Preparedness Planning Coronavirus (COVID-19) Pandemic ---H.R.133: Consolidated Appropriations Act for FY 2021 ---H.R.1319: American Rescue Plan Act of 2021 ---Immunization Information Systems ---R&D Funding for Medical Countermeasures ---Senate HELP Pandemic Preparedness White Paper Funding for Antimicrobial Resistance (AMR) Programs ---FY 2022 Appropriations ---H.R.133: Consolidated Appropriations Act for FY 2021 ---H.R.1319: American Rescue Plan Act of 2021 ---H.R. 8920/S.4760: Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act of 2021 ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 ---Funding for Medical Countermeasures ---Senate HELP Pandemic Preparedness White Paper ---Immunization Information Systems ---Defense Production Act ---Supply Chain Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---FY 2022 Appropriations ---H.R.133: Consolidated Appropriations Act for FY 2021 ---H.R.1319: American Rescue Plan Act of 2021 ---Funding for Strategic National Stockpile ---Health Defense Operations Funding Designation ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020 Funding for National Institutes of Health ---FY 2022 Appropriations ---H.R.133: Consolidated Appropriations Act for FY 2021 ---H.R.1319: American Rescue Plan Act of 2021 ---H.R.3743: Supporting the Foundation for the National Institutes of Health and the Reagan-Udall Foundation for the Food and Drug Administration Act ---Advanced Research Projects Agency for Health (ARPA-H) Funding for the Centers for Disease Control and Prevention Vaccine Programs ---FY 2022 Appropriations ---H.R.133: Consolidated Appropriations Act for FY 2021 ---H.R.1319: American Rescue Plan Act of 2021 ---Funding for 2020-2021 Influenza Season Preparedness and Response ---Funding for Routine Immunization Infrastructure during Pandemic ---Implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act for FY 2020

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); Small Business Administration (SBA); SENATE; Natl Economic Council (NEC); Environmental Protection Agency (EPA); White House Office; Natl Security Council (NSC); Office of Science & Technology Policy (OSTP); Patent & Trademark Office (PTO); Commerce, Dept of (DOC); Agriculture, Dept of (USDA); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC)

Bills named: H.R. 1319 (117th), S. 4760 (117th), H.R. 3743 (117th), H.R. 8920 (117th), H.R. 133 (117th)